Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.
about
Cancer stem cells (CSCs), cervical CSCs and targeted therapiesEpigenetic modulators, modifiers and mediators in cancer aetiology and progressionUnderstanding the Key to Targeting the IGF Axis in Cancer: A Biomarker AssessmentThe links between insulin resistance, diabetes, and cancerRecognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognitionTurning hepatic cancer stem cells inside out--a deeper understanding through multiple perspectives.The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular CarcinomaInsights into the Nanog gene: A propeller for stemness in primitive stem cellsCancer stem cells in basic science and in translational oncology: can we translate into clinical application?The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cellsConcise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding QuestionsSustained proliferation in cancer: Mechanisms and novel therapeutic targetsNanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W speciesInflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular CarcinomaEmerging role of nanog in tumorigenesis and cancer stem cells.HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transitionDecrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1.Regulation of NANOG in cancer cells.Epigenetic regulation of pluripotent genes mediates stem cell features in human hepatocellular carcinoma and cancer cell lines.Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib.Role of IGF1R in Breast Cancer Subtypes, Stemness, and Lineage DifferentiationInsulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance.The role of Nanog expression in tamoxifen-resistant breast cancer cellsLgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal CancerCytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognitionNanog induces suppression of senescence through downregulation of p27KIP1 expression.CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy.Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.The Notch pathway promotes the cancer stem cell characteristics of CD90+ cells in hepatocellular carcinomaThe expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.Strategies for isolating and enriching cancer stem cells: well begun is half doneBile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.Targeting cancer stem cells: emerging role of Nanog transcription factorOncogenic NanogP8 expression regulates cell proliferation and migration through the Akt/mTOR signaling pathway in human gastric cancer - SGC-7901cell lineCWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatmentMEK1 signaling promotes self-renewal and tumorigenicity of liver cancer stem cells via maintaining SIRT1 protein stabilizationGP73-regulated oncolytic adenoviruses possess potent killing effect on human liver cancer stem-like cells.miR-612 suppresses stem cell-like property of hepatocellular carcinoma cells by modulating Sp1/Nanog signaling.In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals.Essential role of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors.
P2860
Q26747144-7543BC1E-97DA-4DDE-9ED3-C63552C46914Q26766149-FBEEABAC-2A9F-4FBB-9D1B-915D3C7874E4Q26798408-D50BF322-0289-461C-94C9-B55F3F4539F0Q26852910-268B8C79-0500-4E69-ACBE-8FCF126A6D4EQ27311035-18F5F131-44B5-4CC3-ABBE-2E06F6E60822Q27692697-74ED8F93-A45D-494F-B74D-0C9E43A4E3B4Q28071619-7CBE4A65-FA94-4165-BC43-ED84D213AEA3Q28073695-BC8C5F79-A6BB-4AE9-BB38-1F42A84D2E63Q28081844-5979D06A-3640-419D-8670-94195EBAFCF6Q28085385-8CA26BEF-FF40-4007-A67B-61464B662518Q28088370-A942F4D5-A881-43E5-8ADE-24E832BDBC87Q28396388-B162DEA3-2947-4983-A491-64272C1456A8Q28540510-AAE94F3C-2FD4-4E2B-9E45-8D567F3529EEQ28550411-9DA0E4DB-AA23-4E6A-BD39-5839686187DEQ33786554-24AC1254-A9BF-4CE0-AD02-81F06E91467CQ33830894-52C8F493-00F2-4C98-BF47-06021D4B103AQ34344549-0AE7C2B4-923B-4D5F-A14D-0067479C45EDQ34478004-FF66748F-60C3-46AA-AAF7-E9CF8754081EQ34983919-3C880222-58F2-4D1F-99F6-98DF5C8E1CFEQ35410105-5EFEDC23-3C4D-408D-A33E-A7920F77D02DQ35535296-BD50EEE8-C8A2-4D59-8D8A-89245C3F41E9Q35606589-3DCD3356-427F-4DA7-BFD4-948A970D34ECQ35703398-EF18A298-0CB2-46A4-AEBF-8BB329EDBBC8Q35849680-2985D688-E61C-4498-9F90-0A1925BAE35DQ36544290-522EF0CB-DC11-4E42-B02B-E0CD4DC5E65BQ36743944-35844B8E-BE79-41C3-B845-02653AA80A9BQ36903909-3EBD79D0-CF73-4532-9D28-F90956A6F8D0Q36905769-E668B911-8CA6-4EAB-9E06-3EA38DB04A71Q36962663-A72029A8-6F3D-4A44-9FD4-30D202349082Q36997962-D3F276D5-7C43-4B87-927A-6E2A41094268Q37061915-34B4331F-6E46-4A6D-BFAD-7FAC9FC84E35Q37139504-214B201B-F704-4519-B953-94C526F6862BQ37170030-2B7090CF-121C-47B3-B6C7-A6C3599D5081Q37174814-91AE826F-AEEA-4972-A8BE-D97C2068C3D1Q37190326-838809C9-56FA-4127-9D2B-A1595FACC747Q37190384-92F9CD8A-17FC-4EB0-873D-AE421DEA9BE6Q37301817-FC3CB37E-01AD-4F91-B8DC-9D2BD2289390Q37330910-87A84519-6737-4610-AAC3-688307DE877AQ37344789-97709F7B-CE6E-420F-8DFB-C427C6188AC0Q37348159-8C8AAC71-E957-48AF-ABBC-C73277227581
P2860
Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Nanog regulates self-renewal o ...... uman hepatocellular carcinoma.
@en
Nanog regulates self-renewal o ...... uman hepatocellular carcinoma.
@nl
type
label
Nanog regulates self-renewal o ...... uman hepatocellular carcinoma.
@en
Nanog regulates self-renewal o ...... uman hepatocellular carcinoma.
@nl
prefLabel
Nanog regulates self-renewal o ...... uman hepatocellular carcinoma.
@en
Nanog regulates self-renewal o ...... uman hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Nanog regulates self-renewal o ...... uman hepatocellular carcinoma.
@en
P2093
Cheng Qian
Guangjie Duan
Juanjuan Shan
Junjie Shen
Qianzhen Zhang
P2860
P304
P356
10.1002/HEP.25745
P407
P50
P577
2012-07-12T00:00:00Z